Innate and adaptive lymphoid cells in the human liver

Immunological Reviews

Volumn 174, Issue , 2000, Pages 5-20

  Doherty, Derek G ^a   O'Farrelly, Cliona ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENT; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TOXIN;

ACUTE PHASE RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGENICITY; CELL HETEROGENEITY; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; HUMAN; IMMUNITY; IMMUNOSTIMULATION; LIVER CELL; LIVER FUNCTION; LYMPHATIC SYSTEM; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NATURAL KILLER CELL; NONHUMAN; PATHOGENICITY; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL;

ACUTE-PHASE PROTEINS; ANTIGEN PRESENTATION; BACTERIAL INFECTIONS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; NEOPLASMS; PHAGOCYTES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES;

EID: 0034113629     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017416.x     Document Type: Review

References (105)

1. 1. Hata K, Zhang XR, Iwatsuki S, Van Thiel DH, Herberman RB, Whiteside TL. Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol 1990;56:401-419.
2. 2. Schlitt H, Raddatz G, Steinhoff G, Wonigheit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993;56:951-955.
3. 3. Pruvot FR, et al. Characterisation, quantification and localisation of passenger T lymphocytes and NK cells in human liver before transplantation. Transplant Int 1995;8:273-279.
4. 4. Norris S, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998;28:84-90.
5. 5. Dubuisson L, et al. Ultrastructure of human liver-associated lymphocytes in vivo and in vitro. In: Bouwens L, ed. NK cells in the liver. Austin (TX): RG Landes Company; 1995. p. 127-154.
6. 6. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease. Hepatology 1992;15:816-823.
7. 7. Winnock M, et al. Functional characterisation of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology 1993;105:1152-1158.
8. 8. Norris S, et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum Immunol 1999;60:20-31.
9. + natural T cells with distinct cytotoxic activites and Th1, Th2 and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-2321.
10. 10. Wisse E, van't Noordende JM, van der Meulen J, Daems WT. The pit cell: description of a new type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 1976;173:423-435
11. 11. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
12. 12. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993;5:503-510.
13. 13. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997;155:53-66.
14. 14. Lanier LL, Corliss B, Phillips JH. Arousal and inhibition of human NK cells. Immunol Rev 1997;155:145-154.
15. 15. Bauer S, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
16. 16. Porgador A, Mandelboim O, Restifo NP, Strominger JL. Natural killer cell lines kill autologous β2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc Natl Acad Sci USA 1997;94:13140-13145.
17. 17. Ikeda H, et al. Characterisation of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997;6:199-208.
18. 18. Moretta A, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597-604.
19. 19. Litwin V, Gumperz J, Parham P, Phillips JP, Lanier LL. NKB1: an NK cell receptor involved in the recognition of HLA-B. J Exp Med 1994;180:537-543.
20. 20. Biassoni R, et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645-650.
21. 21. López-Botet M, et al. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev 1997;155:165-174.
22. 22. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998;92:705-707.
23. 23. Fry A, Lanier LL, Weiss A. Phosphotyrosines in the KIR motif of NKB1 are required for negative signalling and for association with PTP1C. J Exp Med 1996;184:295-300.
24. 24. Reynard V, et al. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 1997;155:205-221.
25. 25. Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998;8:693-701.
26. 26. Wu J, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285:730-732.
27. 27. Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Natural killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 1991;14:495-503.
28. 28. Shimizu Y, Iwatsuki S, Herberman RB, Whiteside TL. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors. Int J Cancer 1990;46:878-883.
29. + T cells in patients with malignancy. Clin Exp Immunol 1994;97:522-527.
30. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996;156:2436-2442.
31. 31. Rowell DL, et al. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am J Physiol 1997;273:322-332.
32. + T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998;28:3448-3455.
33. + T cells preferentially accumulate in human liver. Eur J Immunol 1999;29:2406-2413.
34. 34. Abo T, et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. Int Rev Immunol 1994;11:61-102.
35. + cells in the liver of mice. J Exp Med 1994;180:699-704.
36. 36. Tsukahara A, et al. Mouse liver T cells: their change with aging and comparison with peripheral T cells. Hepatology 1997;26:301-309.
37. + subset. J Immunol 1990;145:1039-1045.
38. H2 response and in immunoglobulin E production. Science 1995;270:1845-1847.
39. + T cells upon NKR-PI cross-linking. J Exp Med 1996;183:2391-2396.
40. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-2249.
41. - T cells in mice and humans. J Exp Med 1994;180:1097-1106.
42. + T lymphocytes. Science 1995;268:863-865.
43. 43. Kawano T, et al. CD1 d-restricted and TCR-mediated activation of Vα14 NK T cells by glycosylceramides. Science 1997;278:1626-1629.
44. + cells: new clues to their origin, specificity, and function. J Exp Med 1995;182:633-638.
45. + T cells: a new family of T cells. Immunol Today 1996;17:71-76.
46. + cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell Immunol 1991;136:486-495.
47. 47. Ferrini S, et al. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 1994;24:2294-2298.
48. 48. Phillips JH. Gumperz JE, Parham P, Lanier LL. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995;268:403-405.
49. 49. Mingari MC, et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 1995;7:697-703.
50. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
51. 51. Leite-De-Moraes MC, et al. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur J Immunol 1998;28:1507-1515.
52. 52. Cui J, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
53. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumour metastasis. J Immunol 1996;56:3366-3373.
54. 54. Satoh M, et al. Cytotoxic γδ or αβ T cells with a natural killer cell marker, CD56, induced from human peripheral lymphocytes by a combination of IL-2 and IL-12. J Immunol 1996;157:3886-3892.
55. + lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. Hum Immunol 1998;59:352-362.
56. 56. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-749.
57. 57. Mandelboim O, et al. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 1996;274:2097-2100.
58. 58. Ohteki T, et al. Predominant appearance of γ/δ T lymphocytes in the liver of mice after birth. Eur J Immunol 1991;21:1733-1740.
59. + intraepithelial lymphocytes. Nature 1988;333:855-858.
60. 60. Battistini L, et al. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors. J Immunol 1997;159:3723-3730.
61. 61. Modlin RL, et al. Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions. Nature 1989;339:544-548.
62. 62. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γδ T cells in vivo. Nature 1995;373:255-257.
63. 63. Wen L, Ma Y, Vergani D, Hayday AC. γδ T cells are active in the liver. In: Crispe IN, ed. T lymphocytes in the liver. Immunobiology, pathology and host defence. New York: Wiley-Liss, 1999. p. 41-58.
64. 64. Constant P, et al. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 1994;264:267-70.
65. 65. Bukowski JF, Morita CT, Brenner MB. Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 1999;11:57-65.
66. 66. Sciammas R, et al. Unique antigen recognition by a herpesvirus-specific TCR-γδ cell. J Immunol 1994;152:5392-5397.
67. 67. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998;279:1737-1740.
68. - cytolytic T lymphocytes. Nature 1989;341:447-450.
69. 69. Faure F, Jitsukawa S, Miossec C, Hercend T. CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood γ/δ cells. Eur J Immunol 1990;20:703-706.
70. + T-cell subset inhibits antigen specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
71. 71. Boismenu R, Havran W. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science 1994;266:1253-1255.
72. - T cells. J Exp Med 1997;186:109-120.
73. 73. Brossay L, et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998;188:1521-1528.
74. 74. Spada FM, Koezuka Y, Porcelli SA. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998;188:1529-1534.
75. 75. Joyce S, et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998;279:1541-1544.
76. 76. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today 1996;17:214-217.
77. 77. Prussin C, Foster B. TCR Vα24 and Vβ11 coexpression defines a unique NK1 T cell analog containing a unique Th0 population. J Immunol 1997;159:5862-5870.
78. 78. Wilson SB, et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 1998;391:177-181.
79. 79. Sumida T, et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995;182:1163-1168.
80. +-like thymocytes in the NOD mouse. Eur J Immunol 1996;26:2989-2998.
81. 81. Porcelli SA, Segelke BW, Sugita M, Wilson IA, Brenner MB. The CD1 family of antigen-presenting molecules. Immunol Today 1998;19:362-368.
82. + T cells. Nature 1994;372:691-694.
83. 83. Sieling PA, et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995;269:227-230.
84. 84. Bleicher PA, Balk SP, Hagen SJ, Blumberg RS, Flotte TJ, Terhorst C. Expression of murine CD1 on gastrointestinal epithelium. Science 1990;250:679-681.
85. 85. Tsuneyama K, Yasoshima M, Harada K, Hiramitsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 1998;28:620-623.
86. 86. Sato K, et al. Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 1995;182:759-767.
87. 87. Rocha B, Guy-Grand D, Vassalli P. Extrathymic T cell differentiation. Curr Opin Immunol 1995;7:235-242.
88. 88. Levelt CN, et al. High-and low-affinity single-peptide/MHC ligands have distinct effects on the development of mucosal CD8αα and CD8αβ T lymphocytes. Proc Natl Acad Sci USA 1999;96:5628-5633.
89. 89. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 2000;174:135-149.
90. 90. Taniguchi H, Toyoshuma T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat Med 1996;2:198-203.
91. 91. Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty J, O'Farrelly C. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver. Hepatology 1999;29:1193-1198.
92. 92. Collins C, et al. RAG1, RAG2 and pre-T cell receptor α chain expression by adult human hepatic T cells: evidence for extrathymic T cell maturation. Eur J Immunol 1996;26:3114-3118.
93. 93. Miyaji C, Watanabe H, Osman Y, Kuwano Y, Abo T. A comparison of proliferative response to IL-7 and expression of IL-7 receptors in intermediate TCR cells of the liver, spleen, and thymus. Cell Immunol 1996;169:159-165.
94. 94. Yoong KF, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by γ-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 1999;30:100-111.
95. + T cells respond to mycobacterial heat-shock protein. Nature 1989;340:309-312.
96. 96. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995;375:155-158.
97. 97. Wen L, Peakman M, Mieli-Vergani G, Vergani D. Elevation of activated γδ T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease. Clin Exp Immunol 1992;89:78-82.
98. 98. Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of γδ T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 1996;23:988-993.
99. 99. Niehues T, Gulwani-Akolkar B, Goldman IS, McKinley MJ, Silver J. Marked γδ T-cell decrease in peripheral blood of patients with primary biliary cirrhosis (PBC). Autoimmunity 1994;18:267-273.
100. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994;152:3074-3087.
101. - double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J Exp Med 1990;172:7-12.
102. + cells and evidence of usage of T and NK cell receptors. Transplantation 1993;58:496-504.
103. + NK T cells is associated with disease development in autoimmune-prone mice. J Immunol 1996;156:4035-4040.
104. intermediate T cells in the liver of normal mice: implications for lpr pathogenesis. Int Immunol 1994;6:533-540.
105. -8 Tαβ-cells in the liver is a common feature of autoimmune mice. J Immunol 1991;147:2907-2912.